Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
GBCC
Previous Meetings
GBCC Information
GBCC Resources
Previous Meetings
Photo Album
Announcement
What’s NEW
Previous Meetings (GBCC 2017)
※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
Day 1, Apr 20 (Thu) Day 2, Apr 21 (Fri) Day 3, Apr 22 (Sat)
07:30-08:10
  • Satellite Symposium 5
      
  • Venue:  
    Halla Hall
  • Enhancing Endocrine Therapy for Hormone Receptor-positive Advanced Breast Cancer
    Sung-Bae Kim (ASAN Medical Center, Korea)Slide ViewVideo ViewAbstract
08:00-09:30
  • Practicing Breast Surgeons Session: 
    Current Issues in Breast Clinic  
  • Venue:  
    Weolla Room
  • Role of KABTS in the Management of Breast Cancer in Korea
    Tae Ik Eom (Hiu Breast & Thyroid Clinic, Korea)Slide View
  • Role of Ultrasound in Breast Cancer Screening
    Dongwon Kim (Daerim St. Mary's Hospital, Korea)Slide View
  • BIRADS Categorization in Practice: Under or Over-categorization of Breast Lesions
    Hyewon Ro (Honest U Surgery Clinic, Korea)Slide View
  • VABB in Breast Clinic
    Kyung Ho Cha (Mamma Breast Clinic, Korea)
  • Current Issues in Breast Clinic
    Junho Kim (Dr. Kim Breast Thyroid Clinic, Korea)Slide View
08:30-09:30
  • Plenary Lecture 5
      
  • Venue:  
    Halla Hall
  • Haute Couture Tailoring of Radiation Therapy in Breast Cancer
    Philip Poortmans (Institut Curie Paris, France)Slide ViewVideo ViewAbstract
09:40-10:50
  • Symposium 5: 
    To Treat or Not  
  • Venue:  
    Halla Hall
  • Survivorship Session: 
    Advances in Breast Cancer Survivor's Care  
  • Venue:  
    Lotus Hall
  • Breast Cancer Survivorship Research and Care Practices from a Japanese Perspective
    Miyako Takahashi (National Cancer Center, Japan)Slide ViewVideo ViewAbstract
  • Life after Breast Cancer in Australia
    Hyukjai Shin (Myongji Hospital, Medical School of Seonam Univ., Korea)Slide ViewVideo ViewAbstract
  • Health Status and Healthcare Utilization of Breast Cancer Survivors
    Jihyoun Lee (Soonchunhyang Univ. Hospital Seoul, Korea)Slide ViewVideo ViewAbstract
  • Oral Presentation 2
      
  • Venue:  
    Weolla Room
  • GENETIC DETERMINANTS OF SPORADIC BREAST CANCER IN A COHORT OF SRI LANKAN POSTMENOPAUSAL WOMEN
    Nirmala Sirisena (Univ. of Colombo, Sri Lanka)Slide ViewAbstract
  • LUMINAL ANDROGEN RECEPTOR AND ANDROGEN RECEPTOR-HIGH TRIPLE-NEGATIVE BREAST CANCERS ARE GENETICALLY SIMILAR TO LUMINAL BREAST CANCERS
    Jisun Kim (ASAN Medical Center, Korea)Slide ViewAbstract
  • CIRCULATING TUMOR DNA PRESENTS VARIABLE CLONAL RESPONSE OF BREAST CANCER DURING NEOADJUVANT CHEMOTX
    Ji-Yeon Kim (Samsung Medical Center (Samsung Seoul Hospital), Korea)Slide ViewAbstract
  • PREDICTIVE ROLE OF FCRR3A-158 POLYMORPHISM AND STROMAL TUMOR INFILTRATING LYMPHOCYTES IN PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER
    Heejung Chae (ASAN Medical Center, Korea)Slide ViewAbstract
  • PHASE II STUDY OF APATINIB PLUS VINORELBINE, A NOVEL COMBINATION OF ALL-ORAL REGIMEN IN HEAVILY PRETREATED PATIENTS WITH METASTATIC HER2-NEGATIVE BREAST CANCER
    Anjie Zhu (Chinese Academy of Medical Science Pumc, China)Abstract
  • BREAST CANCER TRENDS IN YOUNG WOMEN - A SINGAPOREAN PERSPECTIVE
    Yirong Sim (Singhealth Duke-nus Breast Centre, Singapore)Slide ViewAbstract
  • RISK STRATIFICATION WITH ENDOPREDICT SIGNATURE FOR LUMINAL SUBTYPE BREAST CANCERS: RE-ANALYZING MICROARRAY EXPERIMENTS WITH HAN CHINESE ORIGIN
    Chi-Cheng Huang (Cathay General Hospital, Taiwan)Slide ViewAbstract
  • INTRODUCING THE JAPANESE BREAST CANCER REGISTRY AND THE ACTIVITY
    Naoki Hayashi (St. Luke's International Hospital, Japan)Slide ViewAbstract
10:50-12:00
  • Symposium 6: 
    Personalized Therapy  
  • Venue:  
    Halla Hall
  • How to Interpret the Omics Big Data and Apply to the Clinical Practice
    Yu Shyr (Vanderbilt Univ. Medical Center, U.S.A.)Slide ViewVideo ViewAbstract
  • Personalized Adjuvant Therapy Based on Clinical Trials in Breast Cancer: Dream or Reality?
    Martine Piccart (Institut Jules Bordet, Belgium)Slide ViewVideo ViewAbstract
  • Where Are We Now, to the Precision Medicine
    Masakazu Toi (Kyoto Univ. Hospital, Japan)Slide ViewVideo ViewAbstract
  • Education Session 3: 
    Cell Cycle, CDKs and Breast Cancer: A Changing Paradigm  
  • Venue:  
    Lotus Hall
  • Cell Cycle Regulation and Targeting CDK 4/6 for Treatment of Breast Cancer
    Seock-Ah Im (Seoul National Univ., Korea)Video ViewAbstract
  • CDK 4/6 Inhibitors for the Treatment of Breast Cancer: A Review of Clinical Data
    Jin-Hee Ahn (ASAN Medical Center, Korea)Slide ViewVideo ViewAbstract
  • Ongoing Clinical Trials Combining CDK 4/6 Inhibitors and Related Biomarkers
    Soohyeon Lee (Pfizer Oncology, Korea)Slide ViewVideo ViewAbstract
  • Oral Presentation 3
      
  • Venue:  
    Weolla Room
  • EXOSOMAL DEL-1 AS A POTENT DIAGNOSTIC MARKER FOR BREAST CANCER: A PROSPECTIVE COHORT STUDY
    Soo Jung Lee (Kyungpook National Univ. School of Medicine, Korea)Slide ViewAbstract
  • A SINGLE CENTER STUDY OF RISK REDUCING MANAGEMENT IN BRCA MUTATION CARRIERS AFTER DIAGNOSIS OF BREAST CANCER
    Hyokjo Kang (National Cancer Center, Korea)Abstract
  • DNA METHYLATION PATTERNS OF CANCER TISSUES ASSOCIATED WITH BREAST CANCER SURVIVAL
    Choonghyun Ahn (Seoul National Univ. College of Medicine, Korea)Slide ViewAbstract
  • MYBL1 REARRANGEMENTS AND MYB AMPLIFICATION IN BREAST ADENOID CYSTIC CARCINOMA LACKING THE MYB-NFIB FUSION GENE
    Jisun Kim (ASAN Medical Center, Korea)Slide ViewAbstract
  • PREDICOTRS FOR COSMETIC OUTCOME IN ONCOPLASTIC MASTOPEXY TECHNIQUES
    Chin-Yau Chen (National Yang-ming Univ. Hospital, Taiwan)Slide ViewAbstract
  • RANDOMIZED PHASE 2, OPEN-LABEL, DOSE-RANGING STUDY OF A NOVEL, LONG-ACTING G-CSF, EFLAPEGRASTIM (SPI-2012, ROLONTISTM) OR PEGFILGRASTIM FOR THE MANAGEMENT OF NEUTROPENIA IN PATIENTS WITH BREAST CANCER
    Gajanan Bhat (Spectrum Pharmaceuticals, U.S.A.)Slide ViewAbstract
  • WNT-DP103-GSK3β CASCADE PROMOTES WNT/β-CATENIN SIGNALING IN PARENTAL AND STEM CELLS FROM TRIPLE NEGATIVE BREAST CANCER
    Alan Prem Kumar (National Univ. of Singapore, Singapore)Slide ViewAbstract


Back to Previous Meetings+



Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP